Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Furosemide

Related Products

Hot Products

Name

Furosemide

EINECS 200-203-6
CAS No. 54-31-9 Density 1.606 g/cm3
PSA 131.01000 LogP 3.74480
Solubility Soluble in acetone, DMF or methanol. Slightly soluble in water Melting Point 220 °C
Formula C12H11ClN2O5S Boiling Point 582.1 °C at 760 mmHg
Molecular Weight 330.749 Flash Point 305.9 °C
Transport Information UN 1230 3/PG 2 Appearance white to light yellow crystal powder
Safety 7-16-45-53-36/37/39-22 Risk Codes 61-39/23/24/25-11
Molecular Structure Molecular Structure of 54-31-9 (Furosemide) Hazard Symbols ToxicT, FlammableF, IrritantXi
Synonyms

Frumide;Urex-M;Diurin;Uritol;Frusedan;Prefemin;5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid;Depix;Mirfat;Furosix;Aquarid;Chlor-N- (2-furylmethyl)-5-sulfamylanthranilsaeure;Bioretic;4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid;Neo-renal;Furosifar;Puresis;Furosan;Furex;Rusyde;Jenafusid;Aldic;Urian;Furanthril;

Article Data 18

Furosemide Synthetic route

617-88-9

2-Chloromethylfuran

3086-91-7

4-chloro-5-sulfamoylanthranilic acid

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
With potassium bromide In N,N-dimethyl-formamide at 120℃; for 24h; Reagent/catalyst; Solvent; Temperature;97%
4793-48-0

methyl 4-chloro-2-[((furan-2-yl)methyl)amino]-5-sulfamoylbenzoate

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
With water; sodium hydroxide In ethanol at 20℃;88.5%
617-89-0

furan-2-ylmethanamine

2736-23-4

2,4-dichloro-5-sulfamoylbenzoic acid

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In dimethyl sulfoxide at 130℃; for 6h; Solvent; Inert atmosphere;71.2%

Furosemide glucuronide

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
With bile at 37℃; Kinetics; Further Variations:; Reagents; Decomposition;
2736-23-4

2,4-dichloro-5-sulfamoylbenzoic acid

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium ethanolate; pyrographite / ethanol / 2 h / 40 °C
2.1: ethylene glycol / 3 h / 130 - 135 °C
3.1: water / 0.5 h / 65 °C
3.2: 3 h / 0 - 5 °C / pH 3.5 - 4
View Scheme
41733-55-5

4-chloro-N-(2-furfuryl)-5-sulfamoylanthranilic acid sodium salt

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
Stage #1: 4-chloro-N-(2-furfuryl)-5-sulfamoylanthranilic acid sodium salt In water at 65℃; for 0.5h;
Stage #2: With acetic acid In water at 0 - 5℃; for 3h; pH=3.5 - 4;

C36H47Br2ClN2O13S

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
Stage #1: C36H47Br2ClN2O13S With N-ethyl-N,N-diisopropylamine In water; acetonitrile for 1.25h; Sonication;
Stage #2: In water; acetonitrile at 20℃; for 72h; Reagent/catalyst; Temperature;
56447-54-2

4-chloro-2-fluoro-5-chlorosulfonylbenzoic acid

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine; ammonia / tetrahydrofuran / 16 h / 0 - 20 °C
2: N-ethyl-N,N-diisopropylamine / 1,2-dimethoxyethane / 16 h / 130 °C
View Scheme
446-30-0

4-chloro-2-fluorobenzoic acid

54-31-9

4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: chlorosulfonic acid / 0 - 140 °C
2: triethylamine; ammonia / tetrahydrofuran / 16 h / 0 - 20 °C
3: N-ethyl-N,N-diisopropylamine / 1,2-dimethoxyethane / 16 h / 130 °C
View Scheme

Furosemide Chemical Properties

Molecular Structure:

Molecular Formula: C12H11ClN2O5S
Molecular Weight: 330.7441
IUPAC Name:  4-Chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid
Synonyms of Furosemide (CAS NO.54-31-9): Furosemide [USAN:INN:JAN] ; Frumil ; 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid ; 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid ; 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid ; 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid ; 5-(Aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)benzoic acid ; Aisemide ; Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)- ; Chlor-N-(2-furylmethyl)-5-sulfamylanthranilsaeure ; Disemide ; EINECS 200-203-6 ; Golan ; Hydroled ; Jenafusid ; Katlex ; Lasix Retard ; Marsemide ; Novosemide ; Prefemin ; Radisemide ; Selectofur ; Urosemide ; Anthranilic acid, 4-chloro-N-furfuryl-5-sulfamoyl-
CAS NO: 54-31-9
Classification Code: Diuretic ; Diuretics ; Drug / Therapeutic Agent ; Human Data ; Membrane Transport Modulators ; Mutation data ; Natriuretic Agents ; Reproductive Effect ; Sodium Potassium Chloride Symporter Inhibitors ; Tumor data
H bond acceptors: 7
H bond donors: 4
Freely Rotating Bonds: 5
Polar Surface Area: 88.44 Å2
Index of Refraction: 1.657
Molar Refractivity: 75.76 cm3
Molar Volume: 205.8 cm3
Surface Tension: 75.2 dyne/cm
Density: 1.606 g/cm3
Flash Point: 305.9 °C
Enthalpy of Vaporization: 91.55 kJ/mol
Boiling Point: 582.1 °C at 760 mmHg
Vapour Pressure: 2.15E-14 mmHg at 25°C
Melting point: 220 °C
Storage temp: 2-8°C
Appearance: white to light yellow crystal powder
Sensitivity: Light and Air sensitive.
Water solubility: Slightly soluble in water.
Stability: Stable, but light sensitive, air sensitive and hygroscopic. Incompatible with strong oxidizing agents.

Furosemide Uses

 Furosemide (CAS NO.54-31-9) is used as a diuretic and blood pressure reducer and it is sometimes used in the management of severe hypercalcemia in combination with adequate rehydration. As a loop diuretic, Furosemide is used in the treatment of congestive heart failure and edema. Besides, it has also been used to prevent thoroughbred and standardbred race horses from bleeding through the nose during races. And along with some other diuretics, Furosemide(54-31-9) is also included on the World Anti-Doping Agency's banned drug list because of  its alleged use as a masking agent for other drugs.

Furosemide Production

 Furosemide (CAS NO.54-31-9) is prepared by treating 2,4,5-trichlorobenzoic acid with chlorosulfonic acid, and fur-ther treatment with ammonia and furfuryl amine. Furosemide can also be synthesized stating with 2,4-dichlorobenzoic acid (formed by chlorination and oxidation of toluene). Reaction with chlorosulfonic acid is an electrophilic aromatic substitution via the species -SO,Cl- attacking ortho and para to the chlorines and meta to the carboxylate. Ammonolysis to the sulfonamide is followed by nucleophilic aromatic substitution of the loss hindered chlorine by furfurylamine (obtained from furfural-a product obtained by the hydrolysis of carbohydrates).

Furosemide Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 400mg/kg (400mg/kg)   Drugs in Japan Vol. 6, Pg. 725, 1982.
dog LD50 oral 2gm/kg (2000mg/kg)   Drugs in Japan Vol. 6, Pg. 725, 1982.
human TDLo intravenous 1300ug/kg (1.3mg/kg) CARDIAC: OTHER CHANGES

VASCULAR: REGIONAL OR GENERAL ARTERIOLAR CONSTRICTION
Annals of Internal Medicine. Vol. 103, Pg. 1, 1985.
infant TDLo intravenous 1mg/kg/4H-I (1mg/kg)   Archives of Disease in Childhood. Vol. 59, Pg. 907, 1984.
man TDLo intravenous 29mg/kg (29mg/kg) SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR

SENSE ORGANS AND SPECIAL SENSES: TINNITUS: EAR

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED
New England Journal of Medicine. Vol. 282, Pg. 1413, 1970.
mouse LD50 intravenous 308mg/kg (308mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 14, Pg. 44, 1964.
mouse LD50 oral 2gm/kg (2000mg/kg)   European Patent Application. Vol. #0008367,
mouse LD50 unreported 900mg/kg (900mg/kg)   European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 15, Pg. 386, 1980.
rabbit LD50 intravenous 400mg/kg (400mg/kg)   Drugs in Japan Vol. 6, Pg. 725, 1982.
rabbit LD50 oral 800mg/kg (800mg/kg)   Drugs in Japan Vol. 6, Pg. 725, 1982.
rat LD50 intraperitoneal 800mg/kg (800mg/kg)   Acta Poloniae Pharmaceutica. For English translation, see APPFAR. Vol. 42, Pg. 199, 1985.
rat LD50 intravenous 800mg/kg (800mg/kg)   Drugs in Japan Vol. 6, Pg. 725, 1982.
rat LD50 oral 2600mg/kg (2600mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
rat LD50 subcutaneous 4600mg/kg (4600mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
women TDLo intravenous 2500ug/kg/2M- (2.5mg/kg) CARDIAC: PULSE RATE Intensive Care Medicine. Vol. 12, Pg. 54, 1986.
women TDLo oral 6250ug/kg (6.25mg/kg) BEHAVIORAL: MUSCLE WEAKNESS Journal of Toxicology, Clinical Toxicology. Vol. 31, Pg. 341, 1993.
women TDLo oral 120mg/kg/21W- (120mg/kg) KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS Journal of the Royal Society of Medicine. Vol. 79, Pg. 239, 1986.

Furosemide Safety Profile

Hazard Codes of Furosemide (CAS NO.54-31-9): TF
Risk Statements: 61-39/23/24/25-11
61: May cause harm to the unborn child
39/23/24/25: Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed 
11: Highly Flammable
Safety Statements: 7-16-45-53-36/37/39-22
7: Keep container tightly closed 
16: Keep away from sources of ignition - No smoking 
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) 
53: Avoid exposure - obtain special instruction before use 
36/37/39: Wear suitable protective clothing, gloves and eye/face protection 
22: Do not breathe dust
RIDADR: UN 1230 3/PG 2
WGK Germany: 3
RTECS: CB2625000

Furosemide Specification

 Furosemide may undergo hydrolysis at sufficiently low pH. The pH of aqueous solutions should be maintained in the basic range to prevent hydrolysis. Alcohol has been shown to improve the stability of Furosemide. Incompatible with strong oxidizing agents .

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54-31-9